Clive has more than 30 years' experience in life science research, with over 20 years in senior pharmaceutical industry positions, and a degree and PhD in Pharmacology. His expertise includes an in-depth understanding of all facets of drug discovery and development, a broad knowledge of the science and commercial landscape of a variety of therapeutic areas, and solid experience of the pharmaceutical business and finance community supporting the sector.
Clive was co-founder and Chief Executive of Convergence Pharmaceuticals Ltd, which was acquired by Biogen in Jan 2015.
Clive was previously co-founder and Chief Executive of PowderMed Ltd, a vaccines development company acquired by Pfizer in November 2006; before that he was Senior Vice President, Research and Development and a Board member of PowderJect Pharmaceuticals plc until its acquisition by Chiron Vaccines in 2003. Clive began his career in industry at Ciba-Geigy and then GlaxoWellcome, where he left as UK Research Director in 2001. Clive is a recent past Chairman of the BioIndustry Association (BIA), is currently Non-Executive Chairman of Touchlight Genetics Ltd and Centauri Ltd, and Non-Executive Member of the Medicines Discovery Catapult Board.